Quarterly report · Q1

Period2023-12-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥13.4bn2023-12-01 → 2024-02-29Cons.Net sales
Revenue¥52.0bn2022-12-01 → 2023-11-30Cons.Net sales (5-year summary)
Revenue¥12.8bn2022-12-01 → 2023-02-28Cons.Net sales
Operating income¥454m2023-12-01 → 2024-02-29Cons.Operating income
Operating income−¥93m2022-12-01 → 2023-02-28Cons.Operating income
Ordinary income¥480m2023-12-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.4bn2022-12-01 → 2023-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income−¥64m2022-12-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥393m2023-12-01 → 2024-02-29Cons.Income before income taxes
Profit before tax−¥86m2022-12-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥249m2023-12-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥207m2022-12-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥249m2023-12-01 → 2024-02-29Cons.Profit loss
Net income−¥208m2022-12-01 → 2023-02-28Cons.Profit loss
Total assets¥65.9bnat 2024-02-29Cons.Assets
Total assets¥67.3bnat 2023-11-30Cons.Assets
Total assets¥63.6bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥37.2bnat 2024-02-29Cons.Liabilities
Total liabilities¥38.7bnat 2023-11-30Cons.Liabilities
Net assets / equity¥28.7bnat 2024-02-29Cons.Net assets
Net assets / equity¥28.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥26.5bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥6.9bnat 2023-11-30Cons.Cash and deposits
EPS (basic)¥6.322023-12-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.472022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.252022-12-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
Equity ratio43.3%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio42.3%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio41.5%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 61
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-12-01 → 2024-02-29¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-12-01 → 2024-02-29¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-12-01 → 2024-02-29−¥31m
Reconciling Itemsreconcilingrevenue2023-12-01 → 2024-02-29−¥505m
Reconciling Itemsreconcilingrevenue intersegment2023-12-01 → 2024-02-29−¥505m
Reconciling Itemsreconcilingsegment profit2023-12-01 → 2024-02-29¥22m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2023-12-01 → 2024-02-29¥5.9bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2023-12-01 → 2024-02-29¥5.5bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥371m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2023-12-01 → 2024-02-29¥76m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2023-12-01 → 2024-02-29¥3.0bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2023-12-01 → 2024-02-29¥3.0bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥14m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2023-12-01 → 2024-02-29¥93m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥20m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2023-12-01 → 2024-02-29¥112m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2023-12-01 → 2024-02-29¥2.4bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥100m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2023-12-01 → 2024-02-29¥182m
—segment totalrevenue2023-12-01 → 2024-02-29¥13.9bn
—segment totalrevenue external2023-12-01 → 2024-02-29¥13.4bn
—segment totalrevenue intersegment2023-12-01 → 2024-02-29¥505m
—segment totalsegment profit2023-12-01 → 2024-02-29¥463m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-02-29¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-02-29¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-12-01 → 2024-02-29¥505m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-02-29¥432m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-12-01 → 2023-02-28¥55,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-12-01 → 2023-02-28−¥23m
Reconciling Itemsreconcilingrevenue2022-12-01 → 2023-02-28−¥429m
Reconciling Itemsreconcilingrevenue intersegment2022-12-01 → 2023-02-28−¥429m
Reconciling Itemsreconcilingsegment profit2022-12-01 → 2023-02-28¥60m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥4.9bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥4.6bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥341m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28¥26m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥10m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2022-12-01 → 2023-02-28−¥42m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥17m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28−¥105m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥61m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2022-12-01 → 2023-02-28−¥9m
—segment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
—segment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
—segment totalrevenue intersegment2022-12-01 → 2023-02-28¥429m
—segment totalsegment profit2022-12-01 → 2023-02-28−¥130m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-12-01 → 2023-02-28¥429m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-02-28−¥153m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Other clCurrentQuarterInstant1977697000JPY
Current liabilitiesPrior1YearInstant29981620000JPY
Current liabilitiesCurrentQuarterInstant28798213000JPY
Long term loans payablePrior1YearInstant4493332000JPY
Long term loans payableCurrentQuarterInstant4072586000JPY
Deferred tax liabilitiesPrior1YearInstant965738000JPY
Deferred tax liabilitiesCurrentQuarterInstant1102029000JPY
Provision for share based payments nclPrior1YearInstant104846000JPY
Provision for share based payments nclCurrentQuarterInstant105559000JPY
Net defined benefit liabilityPrior1YearInstant2553267000JPY
Net defined benefit liabilityCurrentQuarterInstant2570079000JPY
Other nclPrior1YearInstant554421000JPY
Other nclCurrentQuarterInstant532360000JPY
Noncurrent liabilitiesPrior1YearInstant8671606000JPY
Noncurrent liabilitiesCurrentQuarterInstant8382615000JPY
LiabilitiesPrior1YearInstant38653227000JPY
LiabilitiesCurrentQuarterInstant37180828000JPY
Capital stockPrior1YearInstant4581397000JPY
Capital stockCurrentQuarterInstant4581397000JPY
Capital surplusPrior1YearInstant6574102000JPY
Capital surplusCurrentQuarterInstant6574547000JPY
Retained earningsPrior1YearInstant15462238000JPY
Retained earningsCurrentQuarterInstant15350310000JPY
Treasury stockPrior1YearInstant-525872000JPY
Treasury stockCurrentQuarterInstant-533100000JPY
Shareholders equityPrior1YearInstant26091866000JPY
Shareholders equityCurrentQuarterInstant25973155000JPY
Valuation difference on available for sale securitiesPrior1YearInstant1703144000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant1930979000JPY
Deferred gains or losses on hedgesPrior1YearInstant-94000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant665000JPY
Foreign currency translation adjustmentPrior1YearInstant271021000JPY
Foreign currency translation adjustmentCurrentQuarterInstant274816000JPY
Remeasurements of defined benefit plansPrior1YearInstant354348000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant345720000JPY
Valuation and translation adjustmentsPrior1YearInstant2328419000JPY
Valuation and translation adjustmentsCurrentQuarterInstant2552181000JPY
Non controlling interestsPrior1YearInstant181236000JPY
Non controlling interestsCurrentQuarterInstant206259000JPY
Net assetsPrior1YearInstant28601522000JPY
Net assetsCurrentQuarterInstant28731597000JPY
Liabilities and net assetsPrior1YearInstant67254750000JPY
Liabilities and net assetsCurrentQuarterInstant65912426000JPY
Net salesPrior1YTDDuration12785442000JPY
Net salesCurrentYTDDuration13426497000JPY
Cost of salesPrior1YTDDuration9198509000JPY
Cost of salesCurrentYTDDuration9174235000JPY
Gross profitPrior1YTDDuration3586932000JPY
Gross profitCurrentYTDDuration4252262000JPY
Selling general and administrative expensesPrior1YTDDuration3679862000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-11-30pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-12-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-12-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsconsolidated 2024-02-29pass